Bioprinting is costly but funding allows development to proceed.
Hanaphy 20 [Paul ; 5/28/20; Kingston University Masters degree ; “BRINTER RAISES €1.2M TO FUND LAUNCH OF SCALABLE BIOPRINTER IN NEW MARKETS,” https://3dprintingindustry.com/news/author/paul-hanaphy/]
Finland-based 3D bioprinting start-up Brinter has revealed that it has received €1.2 million worth of investment. Raised via a seed funding round led by early-stage VC firm Innovestor, the capital is set to be used as a means of expanding the company’s operations, allowing it to more easily address the U.S. and European medical markets with its modular 3D bioprinter, which it says could have future organ fabrication applications. “Bioprinting can rapidly unlock the opportunities behind long-running but unrealised science and research, and plays a key role in pushing the frontier of medical science,” said Tomi Kalpio, CEO of Brinter. “This will result in an improved quality of life for patients through the expansion of more personalised treatment and the ongoing development of bioprinted ‘spare parts’ that can save lives.” “WE ARE EXCITED TO HAVE THE BACKING OF INNOVESTOR, WHO CAN HELP US ACCELERATE THE DEVELOPMENT OF OUR OPERATIONAL CAPABILITIES AND SCALE IN NEW GEOGRAPHIES.” Brinter’s bioprinting technology Based in the Finnish city of Turku, and spun-off from the 3D printing bureau 3DTech Ltd, Brinter develops bioprinting systems, modules and inks for medical, research and cosmetics clients. The firm’s offering revolves around its aptly-named ‘Brinter 1,’ which is capable of depositing layers of cell-laden hydrogels into oncological models as well as cancerous and cartilage microtissues. In practise, Brinter clients are able to use the company’s software to turn MRI, X-ray or CT scanning data into CAD models, before printing them into viable soft tissues for use within drug evaluations, in a way that could help accelerate the translation of new medicines into clinics and bring an end to the use of animal testing. Priced at €24,900, Brinter’s machines are far from cheap, but they are also uniquely modular in that users can acquire and add different printheads to access a variety of modalities on a single platform. The company’s Pneuma Tool, for instance, enables the dispensing of low-to-medium viscosity bio-inks, while its premium Visco Heated Tool comes with material temperature-regulating functionality.